Matthew Bennett

Matthew M.
Bennett currently works at Enterprise Consulting Solutions, Inc., as President, CEO, Secretary & Director, NuSil Technology LLC, as Director from 2014, Ontario Systems LLC, as Director from 2019, PROFILE Products LLC, as Director from 2021, HealthComp LLC, as Director from 2020, Covaris, Inc., as Director from 2021, Proterris, Inc., as Director from 2017, and Invidia Capital Management, as Partner from 2025.
Mr. Bennett also formerly worked at HealthPort, Inc., as Chief Executive Officer & Director, CIOX Health LLC, as Vice Chairman of the Board from 2016 to 2021, Cytel, Inc., as Director from 2017 to 2021, Bellerophon Therapeutics, Inc., as Director from 2018 to 2021, New Mountain Capital LLC, as Managing Director from 2016 to 2025, Gelest, Inc., as Director from 2017 to 2020, Real Chemistry, Inc., as Director, Alteon Health LLC, as Director from 2016 to 2018, Avantor, Inc., as Director from 2014 to 2017, Becton, Dickinson & Co., as EVP, Chief Business & Chief Administrative Officer from 2003 to 2007, VIASYS Healthcare, Inc., as Chief Administrative Officer & General Counsel in 2007, Ikaria, Inc., as EVP-Global Medical Operations & General Counsel from 2007 to 2015, Morgan, Lewis & Bockius LLP, as Attorney in 2003, Stradley, Ronon, Stevens & Young LLP, as Litigator, and Sparta Systems, Inc., as Board Member from 2018 to 2019.
Mr. Bennett received his undergraduate degree in 1993 from Princeton University and doctorate degree in 1996 from Villanova University School of Law.